On Monday, Gray Television, Inc. (NYSE:GTN)’s shares inclined 0.95% to $17.05.
Gray Television, Inc. (GTN) declared that its Board of Directors unanimously voted to expand the Board by one seat and elected Elizabeth Russell Neuhoff as a Director to fill that position. Like all Directors, Ms. Neuhoff’s term will run through our next Annual Meeting.
Beth Neuhoff is the President and CEO of Neuhoff Communications, a privately held broadcast radio and digital media company focused on small-to mid-size communities. Since taking command of Neuhoff Communications in August 2012, she has dramatically improved operations and improved its value.
Gray Television, Inc., a television broadcast company, owns and/or operates television stations and digital assets in the United States. The company owns and operates television stations in 44 television markets broadcasting 140 program streams comprising 76 associates of the Big Four netoperates, such as ABC, CBS, NBC, and FOX. Its stations comprise 26 channels associated with the CBS Network, 24 channels associated with the NBC Network, 16 channels associated with the ABC Network, and 10 channels associated with the FOX Network.
World Fuel Services Corp (NYSE:INT)’s shares dropped -1.57% to $40.01.
World Fuel Services Corporation (INT) stated second quarter net income of $29.9 million or $0.42 diluted earnings per share contrast to $48.2 million or $0.68 diluted earnings per share in the second quarter of 2014. Non-GAAP net income and diluted earnings per share for the second quarter, not taking into account share-based compensation and amortization of attained intangible assets were $37.9 million and $0.53, respectively, contrast to $57.9 million and $0.81 in 2014, which also excluded an executive non-renewal charge.
The company’s aviation segment generated gross profit of $85.0 million, an enhance of $2.1 million or 3% sequentially and $3.2 million or 4% year-over-year. The company’s marine segment generated gross profit of $41.8 million, a decrease of $12.1 million or 23% sequentially and $7.0 million or 14% year-over-year. The company’s land segment posted gross profit of $63.6 million, a decrease of $15.0 million or 19% sequentially, but an enhance of $2.7 million or 4% year-over-year.
World Fuel Services Corporation, a fuel logistics, transaction administration, and payment processing company, sells and distributes fuel and related products and services in the aviation, marine, and land transportation industries. It operates through three segments: Aviation, Marine, and Land. The Aviation segment provides fuel and related products and services to commercial airlines, second and third-tier airlines, cargo carriers, regional and low-cost carriers, airports, fixed based operators, corporate fleets, fractional operators, private aircraft, military fleets, and to the U.S and foreign governments. Its aviation-related services comprise fuel administration, price risk administration, arranging ground handling, dispatch services, and arranging air charter; and arranging and providing flight plans, weather reports, and over flight permits.
At the end of Monday s trade, Varian Medical Systems, Inc. (NYSE:VAR)‘s shares dipped -0.38% to $85.74.
Varian Medical Systems (VAR), world leader in radiotherapy, has been awarded an eight-year tender to supply advanced radiotherapy equipment and software to a network of hospitals in Galicia, in the northwest of Spain. Varian booked the order, worth an estimated €21m ($23m), in its fiscal third quarter.
Under the terms of the agreement Varian will supply 10 linear accelerators, counting three advanced TrueBeam™ systems, to five hospitals in the SERGAS network of hospitals in the Galicia region. Varian will also be installing its full suite of treatment planning software and oncology information administration systems across the network.
Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions in the United States. The company operates in two segments, Oncology Systems and Imaging Components. The Oncology Systems segment provides hardware and software products for treating cancer with radiotherapy, stereotactic radiotherapy, stereotactic body radiotherapy, stereotactic radiosurgery, and brachytherapy. Its products comprise linear accelerators, brachytherapy afterloaders, treatment simulation and verification equipment, and accessories; and information administration, treatment planning, and image processing software.
Foamix Pharmaceuticals Ltd (NASDAQ:FOMX), ended its Monday’s trading session with 8.74% gain, and closed at $11.57.
As declared recently by Bayer HealthCare, the U.S. Food & Drug Administration (FDA) has approved Finacea(R) (azelaic acid) Foam, 15% for topical treatment of the inflammatory papules and pustules of mild to moderate rosacea. Papulopustular rosacea is a skin disease causing inflammatory lesions (papules and pustules) on the nose, cheeks, chin and forehead. Finacea(R) Foam was developed as part of a research and development partnership between Foamix Pharmaceuticals Ltd. (FOMX) and Bayer HealthCare, utilizing Foamix’s proprietary foam technology platform. According to a license agreement between the two companies, Foamix is entitled to royalties and certain milestone payments upon commercialization of Finacea(R) Foam.
Foamix Pharmaceuticals Ltd., a clinical-stage specialty pharmaceutical company, develops and commercializes foam-based formulations for the treatment of acne, impetigo, and other skin conditions in the United States, Germany, and Israel. Its lead product candidates comprise FMX101, a novel topical foam formulation which has accomplished a dose-ranging Phase II clinical trial for the treatment of moderate-to-severe acne; and FMX102 that has accomplished a Phase II clinical trial for the treatment of impetigo caused by methicillin-resistant staphylococcus aureus.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.